Douglas Rioux

Title: Douglas Rioux: Innovator in Self-Assembled Gels for Pharmaceutical Applications

Introduction

Douglas Rioux is a notable inventor based in New Haven, CT (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of self-assembled gels that incorporate anti-retroviral drugs. His innovative work aims to enhance treatment methods for diseases such as HIV and hepatitis.

Latest Patents

Douglas Rioux holds a patent for "Self-assembled gels formed with anti-retroviral drugs, prodrugs thereof, and pharmaceutical uses thereof." This patent describes self-assembled gels and methods of making them. The invention allows for a selective range of ratios between an organic solvent and optionally water, or an aqueous solution. This enables combinations of gelators, such as Generally Recognized As Safe (GRAS) amphiphiles or prodrug-based gelators, co-gelators like anti-retrovirals, and solvents to form self-supporting hydrogels or organogels. The resulting gels can be utilized in methods of treating HIV and/or hepatitis.

Career Highlights

Douglas Rioux is affiliated with The Brigham and Women's Hospital, Inc., where he continues to advance his research and innovations. His work has garnered attention for its potential impact on pharmaceutical applications and patient care.

Collaborations

He has collaborated with notable colleagues, including Jeffrey Michael Karp and Nitin Joshi, who share a commitment to advancing medical science through innovative research.

Conclusion

Douglas Rioux's contributions to the field of pharmaceuticals through his patented self-assembled gels represent a significant advancement in treatment options for serious diseases. His work exemplifies the intersection of innovation and healthcare, paving the way for future developments in the industry.